EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Lagis Enterprise Co., Ltd. (6730) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Lagis Enterprise Co., Ltd. TWD 23.27, price TWD 32.10, upside -27.5%, quality 45 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · TW · ISIN TW0006730005

LE Broad data Sep 24, 2026

Lagis Enterprise Co., Ltd.

6730 · TWO

Weak valuationQuality is weak on top of the rich price.

!Fair value 23.27 TWD · Overvalued (−28%)
!Quality 45/100
!Expensive Growth (revenue 5y +8.8 %/yr)
✓Solidly profitable · 13.9% net margin (TTM)
✓Low debt · generates free cash flow
·4.67% dividend yield
✓Ranks above peers (10/14)
!Moderate moat 54/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

48.20 TWD 25.48 TWD Fair Value 23.27 TWD Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 25.48 TWD – 48.20 TWD · fair‑value band 12.40 TWD – 36.50 TWD · the 32.10 TWD price screens above the 23.27 TWD fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Lagis Enterprise Co. in your weekly email

Every Wednesday you see whether Lagis Enterprise Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China.

Show more

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China. Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port kit for TAMIS, and advanced single port device for vNOTES; path cap and shield wound reactors; energy bipolar forceps; suction irrigation systems and irrigation pumps; electrosurgery system; endo endoscopic instruments, include scissors and dissectors, graspers, mini laparoscopy grasping device, and laparoscopic electrode; and retrieval specimen bags. The company sells its products under LAGIS brand name. Lagis Enterprise Co., Ltd. was founded in 2004 and is headquartered in Taichung, Taiwan.

Stock analysis

Lagis Enterprise Co., Ltd. (6730) currently trades at 32.10 TWD, while our model-based Fair Value estimate is 23.27 TWD, implying the stock looks roughly 37.9% overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 36.34 TWD per share, and 9 of the 26 models we run sit above the 32.10 TWD price.

Bear case: the Earnings-Based group reads lowest at 11.43 TWD, and 17 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 12.40 TWD (bear) to 36.50 TWD (bull), the price of 32.10 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Lagis Enterprise Co., Ltd. reported revenue of 488M TWD in FY2025 versus 393M TWD in FY2021, a compound +5.5%/yr. Reported net income was 69.3M TWD in FY2025, compounding +9.1%/yr from FY2021.

Key figures

Market cap 1.2B TWD (≈ $36.6M) · P/E ratio 15.2 · P/S ratio 2.16 · EPS (TTM) 2.11 TWD · Dividend yield 4.7% · Net margin 14.2% · Return on equity 10.5% · Return on assets (EBIT) 9.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −28%, 6730 screens richer than that median.

Fair Value models

Bear 12.40 TWD Fair Value 23.27 TWD Bull 36.50 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.4479 TWD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 7.90 TWD 14.04 TWD 22.90 TWD 78
Growth DCF 8.10 TWD 13.55 TWD 20.97 TWD 77
Residual Income 17.79 TWD 19.35 TWD 24.19 TWD 76
All 26 models by family
DCF Models
FCF DCF 7.90 TWD 14.04 TWD 22.90 TWD 78
Owner Earnings 2.13 TWD 5.39 TWD 10.10 TWD 72
5Y Revenue Exit 13.36 TWD 25.14 TWD 40.19 TWD 71
5Y EBITDA Exit 21.34 TWD 39.90 TWD 61.50 TWD 73
5Y P/E Exit 17.79 TWD 33.33 TWD 49.54 TWD 69
10Y Revenue Exit 10.53 TWD 20.61 TWD 34.09 TWD 64
10Y EBITDA Exit 16.11 TWD 30.56 TWD 49.83 TWD 66
10Y P/E Exit 13.91 TWD 26.13 TWD 40.99 TWD 62
Earnings-Based
Graham-Dodd 12.98 TWD 38.21 TWD 50.54 TWD 65
Lynch FV 8.00 TWD 11.43 TWD 14.86 TWD 61
PEG = 1.0 8.00 TWD 11.43 TWD 14.86 TWD 57
EPV 13.34 TWD 16.14 TWD 18.56 TWD 74
Dividend Discount
Gordon GGM 7.76 TWD 15.47 TWD 23.42 TWD 67
DDM Multi-Stage 7.76 TWD 12.32 TWD 16.33 TWD 66
Multiples
P/E Multiple 31.49 TWD 41.98 TWD 52.48 TWD 63
P/S Multiple 24.33 TWD 32.44 TWD 40.55 TWD 58
P/B Multiple 24.33 TWD 32.44 TWD 40.55 TWD 55
EV/EBIT 26.47 TWD 36.76 TWD 47.05 TWD 66
EV/EBITDA 33.39 TWD 45.99 TWD 58.59 TWD 67
EV/Revenue 17.63 TWD 27.08 TWD 36.52 TWD 53
Asset-Based
NCAV (Graham) 10.50 TWD 14.07 TWD 20.99 TWD 54
Growth DCF
Growth DCF 8.10 TWD 13.55 TWD 20.97 TWD 77
Rev-Margin DCF 13.36 TWD 25.04 TWD 38.18 TWD 71
Economic Profit
Residual Income 17.79 TWD 19.35 TWD 24.19 TWD 76
ROIC Compounder 13.34 TWD 16.14 TWD 18.56 TWD 72
Growth Earnings
Growth-Adj P/E 25.44 TWD 36.34 TWD 47.24 TWD 67

Open the full fair value analysis →

Notify me when 6730 reaches fair value

Put 6730 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 45/100

Of which business quality 48 · Market factors (momentum, volatility) 37

Profitability 42
Margins and returns on capital today
Quality Growth 47
Are margins and returns improving?
Cashflow 57
Earnings quality: real cash, not paper profit
Fin. Strength 82
Balance sheet, leverage, solvency risk
Investment 15
Disciplined investing over empire-building
Low Volatility 78
Calm price path (market factor)
Momentum 27
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 23
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+7.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.1%
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+9.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.7%
Dividend (yield on the price)4.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 18%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +15.8% a year for the price.

6730 screens 38% overvalued. Compare with Intuitive Surgical, Inc →

Compare Lagis Enterprise Co., Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks

Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 45 · Bottom 25%
Fair Value upside −28% · Below median
Profitability
Return on equity (TTM) 11% · Above median
Return on assets 5% · Above median
Net margin (TTM) 14% · Above median
Operating margin (TTM) 17% · Above median
Growth and dividend
Revenue growth −1% · Below median
Dividend yield (TTM) 4.7% · Top 25%
Balance sheet
Debt / equity 0.34× · Highest 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (TTM) 15.2× · Cheapest 25%
P/B 1.54× · Cheaper than median
P/S (TTM) 2.41× · Cheaper than median
P/FCF 0.9× · Cheapest 25%
EV/EBITDA 10.1× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 17
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)42 · sector 25
HEALTH (low debt)83 · sector 96
DIVIDEND (yield)93 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.09 $353.38 −12%
EssilorLuxottica Société anonyme EL €144.70 €159.17 +10%
Medline Inc MDLN $34.30 $30.15 −12%
Becton, Dickinson and Company BDX $182.52 $103.53 −43%
Alcon Inc ALC $65.39 $39.78 −39%
ResMed Inc RMD A$31.70 A$34.87 +10%
West Pharmaceutical Services, Inc WST $375.87 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €215.80 €54.82 −75%
Straumann Holding STMN CHF 96.38 CHF 45.50 −53%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lagis Enterprise Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6730

Frequently asked questions

Is Lagis Enterprise Co., Ltd. (6730) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 23.27 TWD versus a price of 32.10 TWD, about −28% upside (overvalued).
What is the fair value of 6730?
Our model-based fair value for Lagis Enterprise Co., Ltd. is 23.27 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 32.10 TWD.
What is the quality score of 6730?
Lagis Enterprise Co., Ltd. has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lagis Enterprise Co., Ltd. (6730)?
Our model-based price target is the fair value of 23.27 TWD (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 12.40 TWD, optimistic scenario 36.50 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Lagis Enterprise Co., Ltd. stock forecast for 2026?
Our models put fair value at 23.27 TWD, about −28% upside versus a price of 32.10 TWD (overvalued). Cautious scenario 12.40 TWD, optimistic scenario 36.50 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Lagis Enterprise Co., Ltd. (6730)?
Lagis Enterprise Co., Ltd. reported trailing-twelve-month revenue of about 487M TWD (latest available figure, as of Sep 24, 2026).
Does Lagis Enterprise Co., Ltd. pay a dividend?
Lagis Enterprise Co., Ltd. currently shows a dividend yield of about 4.67% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Lagis Enterprise Co., Ltd. (6730)?
For today's price to be fair in a discounted-cash-flow model, Lagis Enterprise Co., Ltd. would have to grow free cash flow by +17.6 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 6730 use?
Our models discount Lagis Enterprise Co., Ltd. at 9.0 %: a base by market capitalisation (nano), damped by beta 0.18, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Lagis Enterprise Co., Ltd. that is +17.6 % per year a year over ten years, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Lagis Enterprise Co., Ltd. (6730) delivered so far?
Over the past 5 years revenue at Lagis Enterprise Co., Ltd. grew +8.8 % a year. The price currently implies +17.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Lagis Enterprise Co., Ltd. (6730) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Lagis Enterprise Co., Ltd. (+17.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Lagis Enterprise Co., Ltd. (6730)?
The free-cash-flow yield on the price is 3.40 %: that much free cash flow Lagis Enterprise Co., Ltd. produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Lagis Enterprise Co., Ltd. (6730)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lagis Enterprise Co., Ltd. it is 23.27 TWD per share (as of Sep 24, 2026), against a price of 32.10 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Lagis Enterprise Co., Ltd. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 6730 trades above its calculated fair value: price 32.10 TWD, fair value 23.27 TWD, a gap of about −28% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6730?
No. The price is what the market pays today (32.10 TWD); the fair value is what the company's own numbers justify (23.27 TWD). For Lagis Enterprise Co., Ltd. the two are 8.83 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Lagis Enterprise Co., Ltd. worth?
The market values Lagis Enterprise Co., Ltd. at about 1.2B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 32.10 TWD; our models calculate a fair value of 23.27 TWD per share.
What do the bullish and bearish scenarios say about 6730?
Our models span a range for Lagis Enterprise Co., Ltd.: cautious scenario 12.40 TWD, base 23.27 TWD, optimistic 36.50 TWD per share (as of Sep 24, 2026, price 32.10 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6730?
Lagis Enterprise Co., Ltd. trades at a price-to-earnings ratio of 15.2 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 23.27 TWD is built from several models across several years. Other multiples: P/B 1.5, P/S 2.4, EV/EBITDA 10.1.
How solid is the balance sheet of Lagis Enterprise Co., Ltd. (6730)?
Balance-sheet figures for Lagis Enterprise Co., Ltd. (as of Sep 24, 2026): return on equity 10.5%, debt of 0.34 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is 6730 from its 52-week high?
Lagis Enterprise Co., Ltd. trades at 32.10 TWD, about 33% below its 52-week high of 48.20 TWD and 2% above the low of 31.50 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 23.27 TWD is for.
Which stocks are comparable to Lagis Enterprise Co., Ltd.?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lagis Enterprise Co., Ltd. stock attractive at the current price?
The data as of Sep 24, 2026: price 32.10 TWD, calculated fair value 23.27 TWD (−28%), Quality Score 45/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6730 calculated?
We run Lagis Enterprise Co., Ltd. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 23.27 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Lagis Enterprise Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lagis Enterprise Co., Ltd. (6730)?
The closing price on Sep 24, 2026 was 32.10 TWD. Our model-based fair value is 23.27 TWD, about −28% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lagis Enterprise Co., Ltd. right now?
The model range is unusually wide (12.40 TWD to 36.50 TWD). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (45/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Lagis Enterprise Co., Ltd.

How large is the market capitalisation of Lagis Enterprise Co., Ltd. (6730)?
The market capitalisation of Lagis Enterprise Co., Ltd. is 1.2B TWD (≈ $36.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lagis Enterprise Co., Ltd. (6730)?
The price-to-sales ratio of Lagis Enterprise Co., Ltd. is 2.16 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lagis Enterprise Co., Ltd. (6730)?
Earnings per share at Lagis Enterprise Co., Ltd. are 2.11 TWD (price ÷ EPS = P/E 15.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Lagis Enterprise Co., Ltd. (6730)?
The dividend yield of Lagis Enterprise Co., Ltd. is 4.7% (payout 71.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Lagis Enterprise Co., Ltd. (6730)?
The net margin of Lagis Enterprise Co., Ltd. is 14.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lagis Enterprise Co., Ltd. (6730)?
The return on equity (ROE) of Lagis Enterprise Co., Ltd. is 10.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lagis Enterprise Co., Ltd. (6730)?
On an EBIT basis the return on assets of Lagis Enterprise Co., Ltd. is 9.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lagis Enterprise Co., Ltd. (6730)?
The operating margin of Lagis Enterprise Co., Ltd. is 17.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lagis Enterprise Co., Ltd. (6730)?
Revenue at Lagis Enterprise Co., Ltd. is growing −1.0% versus a year earlier (3y avg +3.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lagis Enterprise Co., Ltd. (6730)?
Earnings per share at Lagis Enterprise Co., Ltd. are growing −18.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Lagis Enterprise Co., Ltd. (6730) carry?
The net debt of Lagis Enterprise Co., Ltd. is 172M TWD (fiscal year 2025, ≈ 4.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Lagis Enterprise Co., Ltd. in the live analysis

One click puts Lagis Enterprise Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.